Sermorelin
Sermorelin (GHRH 1-29 fragment)
A GHRH fragment studied in growth-hormone-axis research as a shorter-acting alternative to full-length analogs.
What It Is
Sermorelin corresponds to the first 29 amino acids of native GHRH, the shortest fragment reported in the literature to retain GHRH-receptor activity. Full research-brief content for this compound is in progress.
Mechanism in the Research Literature
See the unrl Research Library (/blog) for a full mechanism discussion of GHRH-receptor agonism in current research literature.
Why Purity Verification Matters Here
As with every compound in this library, independent third-party testing and lot-matched Certificates of Analysis are the standard for verifying identity and purity before use in any research context.
Third-party tested. Lot-matched. No exceptions.
Every unrl batch is characterized by independent third-party testing before it ships, not just an in-house spec sheet. Each Certificate of Analysis is tied to the lot number printed on the vial, so what you're holding matches a specific, published result rather than a generic average.
- Independent lab, not manufacturer self-testing
- HPLC purity + mass spectrometry identity confirmation
- Lot-specific CoA, matched to the vial in hand
- Published and searchable in the public COA library
Research Use Only
This page is provided for research and educational purposes only. The compound discussed is a research reference standard, not a dietary supplement, drug, or article for human or veterinary use. Nothing on this page is medical advice, dosing guidance, or a claim of safety or efficacy. No statement has been evaluated by the FDA.
Quick Reference
- Classification
- GHRH(1-29) fragment
- Status
- Full research brief in progress
Buyer Education
